Jean-Simon Diallo

thumb image

Senior Scientist, Cancer Therapeutics Program, Ottawa Hospital Research Institute
Associate Scientist, Faculty of Medicine, University of Ottawa


Full Biography


Cancers of Interest



Research Interests and Clinical Approach

Oncolytic Virotherapy
Viral sensitizers
Combination Immunotherapy


Projects at BioCanRx

Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization


Scalable Vector Manufacturing Enhancement Using Viral Sensitizers


Anti-DEC205 priming in heterologous prime-boost with OVs for sarcoma


Recent Articles

Researchers join the fight against COVID-19


BioCanRX and Partners Announce Funding for Eight New Projects


Introducing the winners of BioCanRx’s 2018 Summer Studentships


From Ottawa to Sao Paulo, Brazil: A BioCanRx Lab Exchange


BioCanRx and partners announce $6.5M in funding for three new projects including a clinical trial


Announcing the winners of BioCanRx’s 2017 Summer Studentships


BioCanRx investigators receive $5M to develop virus therapy for prostate cancer